Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies.

Details

Language :

English

ISSN :

03946320

Volume :

30

Issue :

1

Database :

Complementary Index

Journal :

International Journal of Immunopathology & Pharmacology

Publication Type :

Academic Journal

Accession number :

121748257

Full Text :

https://doi.org/10.1177/0394632016681577